AIRLINK 194.20 Increased By ▲ 0.70 (0.36%)
BOP 9.78 Increased By ▲ 0.14 (1.45%)
CNERGY 7.64 Increased By ▲ 0.11 (1.46%)
FCCL 38.20 Increased By ▲ 0.50 (1.33%)
FFL 15.65 Increased By ▲ 0.05 (0.32%)
FLYNG 26.00 Increased By ▲ 0.41 (1.6%)
HUBC 128.41 Increased By ▲ 1.34 (1.05%)
HUMNL 13.50 No Change ▼ 0.00 (0%)
KEL 4.64 Increased By ▲ 0.06 (1.31%)
KOSM 6.22 Increased By ▲ 0.12 (1.97%)
MLCF 44.40 Increased By ▲ 0.44 (1%)
OGDC 205.89 Increased By ▲ 2.65 (1.3%)
PACE 6.46 Increased By ▲ 0.06 (0.94%)
PAEL 40.85 Decreased By ▼ -0.13 (-0.32%)
PIAHCLA 17.44 Decreased By ▼ -0.05 (-0.29%)
PIBTL 7.77 Increased By ▲ 0.11 (1.44%)
POWER 9.10 Increased By ▲ 0.02 (0.22%)
PPL 177.75 Increased By ▲ 3.50 (2.01%)
PRL 38.30 Increased By ▲ 0.23 (0.6%)
PTC 24.40 Increased By ▲ 0.33 (1.37%)
SEARL 107.58 Increased By ▲ 0.34 (0.32%)
SILK 0.98 Increased By ▲ 0.01 (1.03%)
SSGC 37.20 Increased By ▲ 0.80 (2.2%)
SYM 19.03 Decreased By ▼ -0.01 (-0.05%)
TELE 8.54 Increased By ▲ 0.30 (3.64%)
TPLP 12.14 Increased By ▲ 0.36 (3.06%)
TRG 66.36 Increased By ▲ 1.48 (2.28%)
WAVESAPP 11.86 Increased By ▲ 0.23 (1.98%)
WTL 1.69 Increased By ▲ 0.01 (0.6%)
YOUW 3.98 Increased By ▲ 0.13 (3.38%)
BR100 11,833 Increased By 65 (0.55%)
BR30 35,275 Increased By 311.2 (0.89%)
KSE100 112,396 Increased By 908.4 (0.81%)
KSE30 35,254 Increased By 320 (0.92%)

KARACHI: Bank Alfalah has partnered with Cancer Foundation Hospital to provide life-saving treatment to women battling breast cancer.

As part of this collaboration, Bank Alfalah and Roche Pakistan have contributed a total of PKR 10.75 million towards medication expenses and free-of-cost treatment for five breast cancer patients, ensuring they receive comprehensive treatment.

Mehreen Ahmed, Group Head of Retail Banking, said that Bank Alfalah believes in going beyond business operations to address critical societal issues. “Breast cancer is a major health challenge, and through our partnership with Cancer Foundation Hospital, we aim to provide tangible support to women battling cancer.”

Copyright Business Recorder, 2024

Comments

Comments are closed.